Joshua C. Chao

Joshua C. Chao

Auto-generated profile, based on publicly available information

Joshua C. Chao

Rutgers Robert Wood Johnson Med Sch, Dept Surg, POB 19, MEB 596, New Brunswick, NJ 08903 USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2023 in Surgery
Verified
Journal Article
Closed access
JCJoshua C. Chao
Joshua C. Chao
MKMarin Kheng
Marin Kheng
AMAlexander Manzella
Alexander Manzella
TBToni Beninato
Toni Beninato
ALAmanda M. Laird
Amanda M. Laird

11 October 2024 in Surgery
Verified
Journal Article
Open access
MKMarin Kheng
Marin Kheng
TKTomohiro Ko
Tomohiro Ko
AMAlexander Manzella
Alexander Manzella
JCJoshua C. Chao
Joshua C. Chao
ALAmanda M. Laird
Amanda M. Laird
TBToni Beninato
Toni Beninato
Background: Medicaid expansion has been associated with improved access to surgical care at high- volume centers. Its impact on parathyroidectomy, however, is unclear. We evaluated the association between Medicaid expansion and parathyroidectomy at high- and low-volume centers. Methods: The Vizient Clinical Data Base was queried for parathyroidectomies. Patients were grouped by insurance status and preand post-Medicaid expansion periods. Hospitals were stratified into tertiles (T1-T3) by operative volume (T1 = highest-volume centers). Odds of parathyroidectomy and a difference-in-differences analysis were conducted. Results: In total, 31,983 patients were identified. Patients were predominantly privately insured (49.9%). Uninsured and Medicaid patients had increasing odds of operation at lower-tertile centers (odds ratio: T1 = ref; uninsured: T2 = 10.0, T3 = 15.8; Medicaid: T2 = 6.2, T3 = 13.5; P < .001). Medicare patients, however, were less likely to undergo operation at lower-volume centers (odds ratio: T2 = 0.89, P < .001; T3 = 0.92, P = .002). Privately insured patients were the least likely to receive care at low-volume centers (odds ratio: T3 = 0.7, P < .001). Medicaid patients in nonexpansion states had 12e16 times higher odds of parathyroidectomy at lower- volume hospitals than their counterparts in expansion states (expansion/nonexpansion states: preexpansion T3 = 2.3/28.0; postexpansion T3 = 1.3/21.4). Expansion was associated with an increase in the proportion of parathyroidectomy for Medicaid patients, with larger gains seen at higher-volume centers (T1 = 5.0%, P = .01; T2 = 3.1%, P = .001; T3 = 2.7%, P = .03). Expansion was not associated with changes in payor distribution for uninsured, Medicare, or privately insured patients. Conclusions: Medicaid expansion was associated with an increase in parathyroidectomy for Medicaid patients at high-volume centers. However, in nonexpansion states, access to surgical treatment at high- volume centers remains limited for uninsured and underinsured patients. (c) 2024 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

18 May 2024 in Surgery
Verified
Journal Article
Closed access
AMAlexander Manzella
Alexander Manzella
MKMarin Kheng
Marin Kheng
JCJoshua Chao
Joshua Chao
ALAmanda M. Laird
Amanda M. Laird
TBToni Beninato
Toni Beninato

1 October 2020 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
JCJoshua C. Chao
Joshua C. Chao
YQYanmei Qi
Yanmei Qi
JLJie Liu
Jie Liu
MSMark P. Scheuerman
Mark P. Scheuerman
LLLeonard Y. Lee
Leonard Y. Lee
SLShaohua Li
Shaohua Li

1 November 2021 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
PDF file
ALAnthony Lemaire
Anthony Lemaire
JCJoshua Chao
Joshua Chao
HIHirohisa Ikegami
Hirohisa Ikegami
LLLeonard Y. Lee
Leonard Y. Lee

20 June 2023 in Diabetes
Verified
Journal Article
Open access
YQYanmei Qi
Yanmei Qi
JLJie Liu
Jie Liu
JCJoshua C. Chao
Joshua C. Chao
SRSaum A. Rahimi
Saum A. Rahimi
LLLeonard Y. Lee
Leonard Y. Lee
SLShaohua Li
Shaohua Li
CREG1 is a small glycoprotein in the endosomal-lysosomal system involved in endocytic trafficking. It contains 3 N-linked glycosylation sites and is highly expressed in the liver. To elucidate its physiological functions, we generated Creg1fl/fl mice using CRISPR technology. Whole-body and hepatocyte-specific deletion of Creg1 was achieved by crossing Creg1fl/fl with UBC-cre-ERT2 and Albumin-cre mice, respectively. Both knockout mice developed elevated glycemia, glucose intolerance, and resistance to the blood glucose-lowering effect of insulin. Loss of hepatic CREG1 also aggravated high-fat diet-induced insulin resistance and hyperinsulinemia. This is likely caused by impaired insulin receptor (IR) trafficking because IR expression on the hepatocyte surface was significant reduced in hepatocyte specific Creg1 knockout mice. In in vitro studies using cultured hepatocytes, CREG1 overexpression increased IR recycling to the cell surface and enhanced insulin signaling, whereas its knockdown had the opposite effect. These findings indicate a cell autonomous role of CREG1 in hepatocyte IR trafficking and insulin signaling. Furthermore, SNP database survey identified 3 missense mutations of CREG1 at the N216 glycosylation site (N216I, N216K, and N216Y). When overexpressed in human hepatocytes, the N216I mutant inhibited insulin signaling in a dominant negative fashion. Taken together, these results suggest CREG1 regulates hepatic insulin sensitivity and signaling likely through its effect on IR trafficking. CREG1 glycosylation at N216 may be required for its function in these processes. Disclosure: Y.Qi: None. J.Liu: None. J.C.Chao: None. S.A.Rahimi: None. L.Y.Lee: Speaker's Bureau; Abbott. S.Li: None. Funding: Rutgers Biomedical and Health Sciences